Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The therapeutic effectiveness of Crisaborole as a treatment for atopic dermatitis is deeply rooted in its unique chemical structure and the resulting mechanism of action. As a novel oxaborole, Crisaborole stands out in the pharmaceutical landscape, particularly due to the presence of a boron atom within its molecular framework. This structural characteristic is not merely ornamental; it plays a pivotal role in how Crisaborole interacts with its biological target. NINGBO INNO PHARMCHEM CO.,LTD. supplies this crucial chemical entity for various applications.
At its core, Crisaborole is a phosphodiesterase 4 (PDE-4) inhibitor. PDE-4 enzymes are critical in regulating intracellular levels of cyclic adenosine monophosphate (cAMP). By inhibiting PDE-4, Crisaborole effectively increases cAMP levels, which in turn suppresses the inflammatory cascade responsible for the symptoms of atopic dermatitis. The specific binding of Crisaborole to the catalytic site of PDE-4 is influenced by its molecular architecture, including the boron atom, which can form specific interactions within the enzyme's active site.
The boron atom in Crisaborole's structure is particularly noteworthy. Boron is known to form Lewis acid-base interactions and can act as a bioisostere for carbon in certain contexts. In Crisaborole, the boron atom is part of the oxaborole ring system and is crucial for its ability to bind to the bimetallic center of the PDE-4 enzyme. This interaction is thought to be key to its potent inhibitory activity. Furthermore, this boron moiety is believed to facilitate the compound's penetration through the stratum corneum, the outermost layer of the skin, allowing it to reach target cells and enzymes more effectively.
Understanding the chemical synthesis of Crisaborole is also important for ensuring its quality and purity. The manufacturing process must be carefully controlled to produce a high-purity API, free from potentially harmful byproducts. NINGBO INNO PHARMCHEM CO.,LTD. leverages advanced chemical synthesis techniques to produce Crisaborole that meets the stringent requirements of the pharmaceutical industry. This includes rigorous analytical testing to confirm identity, purity, and potency.
The detailed knowledge of Crisaborole's chemistry, from its oxaborole ring to its boron atom and its resultant interaction with PDE-4, underpins its successful application in dermatological treatments. NINGBO INNO PHARMCHEM CO.,LTD. is proud to contribute to this field by providing a reliable supply of high-quality Crisaborole API, supporting both current therapeutic needs and future research endeavors in inflammatory skin diseases.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
